Given the potential of novel antibody therapies in the treatment of oncological disorders, there is a growing interest in evaluating such therapy candidates against other life-threatening disease indications as well

The recent rise in the incidence of the monkeypox disease, also known as Mpox, has compelled both industry players and regional government authorities to undertake active initiatives in order to control the spread of the disease

The present treatment landscape of chronic wound and bone healing is characterized by a variety of unmet needs; tissue engineering-based regeneration products have emerged as a viable therapeutic option, which is capable of catering to the growing demand